Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profound Medical Corp. - common stock (NQ:PROF)

5.680 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.680
Bid (Size) 2.280 (2)
Ask (Size) 8.970 (1)
Prev. Close 5.680
Today's Range 5.680 - 5.680
52wk Range 3.895 - 10.95
Shares Outstanding 20,208,948
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
From Profound Medical Corp.
Via GlobeNewswire

Performance

YTD
-28.1%
-28.1%
1 Month
-5.3%
-5.3%
3 Month
+19.8%
+19.8%
6 Month
-18.2%
-18.2%
1 Year
-45.9%
-45.9%

More News

Read More
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Profound Medical Announces First Quarter 2025 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
From Profound Medical Corp.
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
Profound Medical AUA 2025 Investor Event Agenda
From Profound Medical Corp.
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Profound Medical Corp. – PROF
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
From Pomerantz LLP
Via GlobeNewswire
Save the Date: Profound Medical to Host Investor Event at AUA 2025
From Profound Medical Corp.
Via GlobeNewswire
PROF Investors Have Opportunity to Join Profound Medical Corp. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Securities Fraud Investigation Into Profound Medical Corp. (PROF) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay & Murray LLP
Via Business Wire

Frequently Asked Questions

Is Profound Medical Corp. - common stock publicly traded?
Yes, Profound Medical Corp. - common stock is publicly traded.
What exchange does Profound Medical Corp. - common stock trade on?
Profound Medical Corp. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Profound Medical Corp. - common stock?
The ticker symbol for Profound Medical Corp. - common stock is PROF on the Nasdaq Stock Market
What is the current price of Profound Medical Corp. - common stock?
The current price of Profound Medical Corp. - common stock is 5.680
When was Profound Medical Corp. - common stock last traded?
The last trade of Profound Medical Corp. - common stock was at 07/25/25 04:00 PM ET
What is the market capitalization of Profound Medical Corp. - common stock?
The market capitalization of Profound Medical Corp. - common stock is 114.79M
How many shares of Profound Medical Corp. - common stock are outstanding?
Profound Medical Corp. - common stock has 115M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.